LiveOne, Inc. (LVO): Nasdaq/NYSE listing notice — LiveOne receives Nasdaq deficiency notice for bid price below $1.00

LiveOne, Inc.

On October 28, 2022, Nasdaq notified LiveOne that its stock fails the minimum $1.00 bid price rule based on 30 consecutive business days.
The company has 180 calendar days until April 26, 2023 to regain compliance; closing bid must be $1.00+ for 10 consecutive business days.
If not cured, LiveOne may be eligible for a second 180-day period by meeting other listing standards and notifying intent to cure via reverse split.
Failure to regain compliance could lead to delisting; the company may appeal any delisting determination to a Nasdaq hearings panel.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.99

LiveOne, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2)

Exact text from the filing

October 28, 2022, LiveOne, Inc. (the “Company”) received a notification letter from the Listing Qualifications Department of The Nasdaq Stock Market, LLC (“Nasdaq”) notifying the Company that, based on the closing bid price for the previous 30 consecutive business days, the listing of the Company’s shares of common stock was not in compliance with Nasdaq Listing Rule 5550(a)(2) to maintain a minimum bid price of $1.00 per share (the “Bid Price Rule”). The letter from Nasdaq has no immediate effect on the listing of the Company’s common stock on The Nasdaq Capital Market. In accordance with Nas

View on SEC.gov

Browse all listing & compliance notices →

LiveOne, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-22-069006

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.